返回
Bright Minds Biosciences Inc（DRUG）价格
DRUG 股价走势图
DRUG 收益
Bright Minds Biosciences Inc
$88
-2.12%
$-1.9
收盘价：Jan 16, 16:00:00 GMT-5
$89.74
1.97%
$1.73
盘后：Jan 16, 20:00:00 GMT-5
关键数据
前收盘价
$89.91
开盘价
$89.59
当日区间
$86.39 - $89.74
52周范围
$23.17 - $123.75
交易量
111.4K
平均成交量
209.4K
每股收益（TTM）
-1.30
股息收益率
--
市值
$698.8M
什么是 DRUG？
Bright Minds Biosciences, Inc. is a biotechnology company, which engages in the development of therapeutics. The company is headquartered in New York City, New York and currently employs 0 full-time employees. The company went IPO on 2021-02-08. The firm is focused on developing highly selective 5-HT2 agonists for the treatment of drug-resistant epilepsy, depression, and other central nervous system (CNS) disorders. Its Serotonin (5-HT) is a neurotransmitter in the brain and modulates many biological functions. Dysfunction of serotonin receptors, transporters, and associated neurocircuits is fundamental to many diseases including epilepsies and neuro psychiatric. Its pipeline includes BMB-101, BMB-xxx, BMB-201, and BMB-202. The firm has a portfolio of patented, selective serotonin (5-HT2C, 5-HT2A and 5-HT2C/A-receptor subtypes) agonists that were identified by using high-throughput screening methods in combination with advanced molecular modeling techniques to interrogate the interaction between the drug and its targeted receptors to increase downstream signaling.